Myles Minter
Stock Analyst at William Blair
(1.30)
# 3,595
Out of 4,915 analysts
21
Total ratings
52.94%
Success rate
-9.38%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Myles Minter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DNTH Dianthus Therapeutics | Initiates: Outperform | n/a | $20.87 | - | 1 | Jul 2, 2025 | |
| VIGL Vigil Neuroscience | Downgrades: Market Perform | n/a | $8.05 | - | 1 | May 22, 2025 | |
| IMUX Immunic | Initiates: Outperform | n/a | $0.94 | - | 1 | Mar 25, 2025 | |
| CAMP Camp4 Therapeutics | Initiates: Outperform | n/a | $1.66 | - | 1 | Nov 5, 2024 | |
| ARGX argenx SE | Upgrades: Outperform | n/a | $670.33 | - | 2 | Nov 1, 2024 | |
| KRRO Korro Bio | Initiates: Outperform | n/a | $14.96 | - | 1 | Aug 14, 2024 | |
| NMRA Neumora Therapeutics | Initiates: Outperform | n/a | $1.96 | - | 1 | Oct 10, 2023 | |
| ARCT Arcturus Therapeutics Holdings | Initiates: Outperform | $71 | $12.21 | +481.49% | 1 | Jul 24, 2023 | |
| MRNA Moderna | Initiates: Market Perform | n/a | $29.56 | - | 1 | Jul 24, 2023 | |
| VRTX Vertex Pharmaceuticals | Initiates: Outperform | n/a | $456.87 | - | 1 | May 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $54.15 | - | 2 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $3.46 | - | 3 | Sep 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $392.24 | - | 1 | Jun 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $42.98 | - | 2 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.49 | - | 1 | Sep 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $116 | $128.23 | -9.54% | 1 | Feb 24, 2020 |
Dianthus Therapeutics
Jul 2, 2025
Initiates: Outperform
Price Target: n/a
Current: $20.87
Upside: -
Vigil Neuroscience
May 22, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $8.05
Upside: -
Immunic
Mar 25, 2025
Initiates: Outperform
Price Target: n/a
Current: $0.94
Upside: -
Camp4 Therapeutics
Nov 5, 2024
Initiates: Outperform
Price Target: n/a
Current: $1.66
Upside: -
argenx SE
Nov 1, 2024
Upgrades: Outperform
Price Target: n/a
Current: $670.33
Upside: -
Korro Bio
Aug 14, 2024
Initiates: Outperform
Price Target: n/a
Current: $14.96
Upside: -
Neumora Therapeutics
Oct 10, 2023
Initiates: Outperform
Price Target: n/a
Current: $1.96
Upside: -
Arcturus Therapeutics Holdings
Jul 24, 2023
Initiates: Outperform
Price Target: $71
Current: $12.21
Upside: +481.49%
Moderna
Jul 24, 2023
Initiates: Market Perform
Price Target: n/a
Current: $29.56
Upside: -
Vertex Pharmaceuticals
May 30, 2023
Initiates: Outperform
Price Target: n/a
Current: $456.87
Upside: -
Mar 6, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $54.15
Upside: -
Sep 19, 2022
Upgrades: Outperform
Price Target: n/a
Current: $3.46
Upside: -
Jun 7, 2022
Initiates: Outperform
Price Target: n/a
Current: $392.24
Upside: -
Dec 14, 2021
Upgrades: Outperform
Price Target: n/a
Current: $42.98
Upside: -
Sep 27, 2021
Initiates: Outperform
Price Target: n/a
Current: $1.49
Upside: -
Feb 24, 2020
Initiates: Outperform
Price Target: $116
Current: $128.23
Upside: -9.54%